When a person develops diabetes at a young age, is not overweight, and has several family members with the condition, is it really type 2 diabetes? In many cases, the answer may be no. A growing body of evidence suggests that thousands of people worldwide are living with HNF1A-MODY, a …
Read More »Farxiga Just Went Generic—Will Lower Prices Finally Change Diabetes Care?
For many people living with type 2 diabetes, the biggest challenge is not finding an effective medication. It is being able to afford it. That reality may begin to change now that the U.S. Food and Drug Administration (FDA) has approved the first generic versions of Farxiga (dapagliflozin), potentially making …
Read More »The “Graveyard Shift” Penalty: Why Night-Shift Workers Face a Hidden Diabetes Challenge
Night-shift work keeps hospitals, factories, transportation systems, and emergency services running around the clock. However, while society benefits from overnight workers, their metabolic health often pays the price. Recent continuous glucose monitoring (CGM) studies have shown that shift work is strongly associated with greater glycemic variability in people with diabetes, …
Read More »Morning or Evening? New Research Suggests Exercise Timing May Change Diabetes Outcomes
For years, diabetes care has emphasized one simple message: exercise regularly. While that advice remains essential, researchers are now asking a more specific question. Could when you exercise be just as important as how much you exercise? Emerging evidence suggests the answer may be yes. The growing field of chronotherapy, …
Read More »The Hidden Cost of Diabetes Care: Why Treatment Burden Is Becoming a Clinical Outcome
Managing diabetes has never offered more therapeutic options. Continuous glucose monitors (CGMs), automated insulin delivery systems, GLP-1 receptor agonists, SGLT2 inhibitors, and individualized treatment plans have transformed patient care. Yet despite these advances, many people with diabetes continue to struggle, not because treatments are ineffective, but because the overall workload …
Read More »The Return of C-Peptide: Why This Old Biomarker Is Finding New Clinical Uses
For many years, C-peptide testing was viewed as a simple tool to distinguish type 1 diabetes from type 2 diabetes. However, the story has changed. As researchers gain a better understanding of pancreatic beta-cell function, C-peptide testing in diabetes has become much more valuable than a diagnostic aid alone. Today, …
Read More »When Cardiology Meets Endocrinology: Why Diabetes Care Is Becoming a Team Sport
Not long ago, diabetes management focused primarily on controlling blood glucose levels. Today, that approach has evolved dramatically as cardiologists and endocrinologists increasingly work together to reduce cardiovascular risk. Thanks to groundbreaking cardiovascular outcome trials (CVOTs), clinicians now understand that treating type 2 diabetes means protecting the heart, kidneys, and …
Read More »When Weight Loss Isn’t the Whole Story: Managing Binge Eating Disorder in Type 2 Diabetes
For many people living with binge eating disorder and type 2 diabetes, managing blood sugar isn’t just about counting carbohydrates or losing weight. Emotional eating, loss of control around food, and feelings of guilt can quietly interfere with diabetes care, even when someone is taking the right medications. Because of …
Read More »Why Blood Sugar Changes Every Month: Using CGM to Manage Luteal Phase Insulin Resistance
Many women with diabetes notice that blood sugar levels become harder to control during certain weeks of the month. Despite eating the same meals, taking the same insulin doses, and maintaining consistent activity levels, glucose readings may suddenly climb. This recurring pattern is often linked to luteal phase insulin resistance, …
Read More »After CGM, Is Continuous Lactate Monitoring the Next Big Breakthrough?
Continuous glucose monitoring (CGM) has fundamentally changed diabetes management by giving patients and clinicians access to real-time glucose data. As a result, treatment decisions have become more precise, and many people with diabetes now spend more time within their target glucose range. However, glucose represents only one part of the …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.